Search research articles
Contact Us
Filters
Showing results (1311-1320 of 1,327) with videos related to
Page
of 133
Sort By:
The New Phytologist
|
July 22, 2014
Climate refugia: joint inference from fossil records, species distribution models and phylogeography
Daniel G Gavin, Matthew C Fitzpatrick, Paul F Gugger, et al.
American Heart Journal
|
February 22, 2023
Prospective randomized comparison between upgraded '2C3L' vs. PVI approach for catheter ablation of persistent atrial fibrillation: PROMPT-AF trial design
Xiao-Xia Liu, Qiang Liu, Yi-Wei Lai, et al.
International Journal of Biological Sciences
|
November 7, 2017
Distinct Effects of Ca<sup>2+</sup> Sparks on Cerebral Artery and Airway Smooth Muscle Cell Tone in Mice and Humans
Qing-Yang Zhao, Yong-Bo Peng, Xiao-Jing Luo, et al.
Signal Transduction and Targeted Therapy
|
February 27, 2025
Safety, pharmacokinetics and efficacy of HA121-28 in patients with advanced solid tumors and RET fusion-positive non-small-cell lung cancer: a multicenter, open-label, single-arm phase 1/2 trial
Dan-Yun Ruan, Wen-Wen Huang, Yongsheng Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 1, 2022
Efficacy and Safety of Rezivertinib (BPI-7711) in Patients With Locally Advanced or Metastatic/Recurrent EGFR T790M-Mutated NSCLC: A Phase 2b Study
Yuankai Shi, Shiman Wu, Ke Wang, et al.
Cancer Communications (London, England)
|
October 26, 2021
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
Ling-Long Tang, Yu-Pei Chen, Chuan-Ben Chen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2025
Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study
Zhengbo Song, Ziming Li, Yiping Zhang, et al.
JAMA Oncology
|
November 14, 2024
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer: The Phase 3 EXTENTORCH Randomized Clinical Trial
Ying Cheng, Wei Zhang, Lin Wu, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2024
Camrelizumab plus carboplatin and pemetrexed as first-line therapy for advanced non-squamous non-small-cell lung cancer: 5-year outcomes of the CameL randomized phase 3 study
Caicun Zhou, Gongyan Chen, Yunchao Huang, et al.
The Lancet. Respiratory Medicine
|
February 6, 2025
Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study
Yuankai Shi, Yanzhen Guo, Xingya Li, et al.
Page
of 133
Search research articles
Search
Showing results (1311-1320 of 1,327) with videos related to
Sort By:
Page
of 133
The New Phytologist
|
July 22, 2014
Climate refugia: joint inference from fossil records, species distribution models and phylogeography
Daniel G Gavin, Matthew C Fitzpatrick, Paul F Gugger, et al.
American Heart Journal
|
February 22, 2023
Prospective randomized comparison between upgraded '2C3L' vs. PVI approach for catheter ablation of persistent atrial fibrillation: PROMPT-AF trial design
Xiao-Xia Liu, Qiang Liu, Yi-Wei Lai, et al.
International Journal of Biological Sciences
|
November 7, 2017
Distinct Effects of Ca<sup>2+</sup> Sparks on Cerebral Artery and Airway Smooth Muscle Cell Tone in Mice and Humans
Qing-Yang Zhao, Yong-Bo Peng, Xiao-Jing Luo, et al.
Signal Transduction and Targeted Therapy
|
February 27, 2025
Safety, pharmacokinetics and efficacy of HA121-28 in patients with advanced solid tumors and RET fusion-positive non-small-cell lung cancer: a multicenter, open-label, single-arm phase 1/2 trial
Dan-Yun Ruan, Wen-Wen Huang, Yongsheng Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 1, 2022
Efficacy and Safety of Rezivertinib (BPI-7711) in Patients With Locally Advanced or Metastatic/Recurrent EGFR T790M-Mutated NSCLC: A Phase 2b Study
Yuankai Shi, Shiman Wu, Ke Wang, et al.
Cancer Communications (London, England)
|
October 26, 2021
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
Ling-Long Tang, Yu-Pei Chen, Chuan-Ben Chen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2025
Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study
Zhengbo Song, Ziming Li, Yiping Zhang, et al.
JAMA Oncology
|
November 14, 2024
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer: The Phase 3 EXTENTORCH Randomized Clinical Trial
Ying Cheng, Wei Zhang, Lin Wu, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2024
Camrelizumab plus carboplatin and pemetrexed as first-line therapy for advanced non-squamous non-small-cell lung cancer: 5-year outcomes of the CameL randomized phase 3 study
Caicun Zhou, Gongyan Chen, Yunchao Huang, et al.
The Lancet. Respiratory Medicine
|
February 6, 2025
Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study
Yuankai Shi, Yanzhen Guo, Xingya Li, et al.
Page
of 133